脑部放疗,上午比下午敏感许多!+ w; V6 h& u1 r& {7 {) b: u
7 I! b1 }- L# ~9 [. e0 B% u6 f+ u! E. _7 C% F! D
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.) S. R0 Q6 g' ^/ ?, U
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?( F7 ?1 U# r. X+ s( m! r. q6 n! O; f6 U
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
7 w2 v. t& D/ W- S* O: LSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA./ b0 N/ B2 d1 D" ?; L/ [
$ i3 U8 W; W3 l$ K+ B! b, L5 C
Abstract
% s3 ]3 V: u; s- _BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.1 U' J# m( I% d3 \6 i# X( y5 O
; o& I7 a4 F3 h* LMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.6 F7 |( i4 V+ ~& }0 _* x! o/ i! l
* J; p; v2 Z% G7 _' n5 WRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
u' E1 g& {; D2 A* m; P( c
1 M! [' F; z6 T' ]2 v' QCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series. _& X/ g9 z+ O3 T6 p
# ^' _8 Y) y! Z& V& c, }8 \2 C- s
|